Aspergillus oryzae Fermentation Extract Alleviates Inflammation in Mycoplasma pneumoniae Pneumonia
Molecules · 2023
DOI: 10.3390/molecules28031127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Hui-Yu Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Science and Technology, National Taiwan University, Taipei 10617, Taiwan. Hauptthemen laut MEDLINE: Aspergillus oryzae, Pneumonia, Mycoplasma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University, King's Ground Biotech Co., Ltd., King’s Ground Biotech Co., Ltd..
Abstract (Originalsprache)
The filamentous fungus Aspergillus oryzae, also known as koji mold, has been used for centuries in the production of fermented foods in East Asia. A. oryzae fermentation can produce enzymes and metabolites with various bioactivities. In this study, we investigated whether A. oryzae fermentation extract (AOFE) has any effect on Mycoplasma pneumoniae (Mp) pneumonia. We performed solid-state fermentation of A. oryzae and obtained the ethanol extract. AOFE was analyzed by HPLC, and the major component was identified to be kojic acid. In vitro, AOFE suppressed Mp growth and invasion into A549 lung epithelial cells as determined by the gentamicin protection assay. AOFE treatment also suppressed Mp-stimulated production of tumor necrosis factor (TNF)-α and interleukin (IL)-6 at mRNA and protein levels in murine MH-S alveolar macrophages. In a mouse model of Mp pneumonia, Mp infection induced a marked pulmonary infiltration of neutrophils, which was significantly reduced in mice pre-treated orally with AOFE. AOFE administration also suppressed the production of proinflammatory cytokines and chemokines in the lungs. Collectively, our results show that AOFE has the potential to be developed into a preventive/therapeutic agent for Mp pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Science and Technology, National Taiwan University, Taipei 10617, Taiwan.
- King's Ground Biotech Co., Ltd., Pintung 91252, Taiwan.
ORCID-Profile: Chun-Jen Chen
Förderung
- National Taiwan University
- King's Ground Biotech Co., Ltd.
- King’s Ground Biotech Co., Ltd.
Zitieren
APA
Lee, H. Y., Chen, C. C., Pi, C. C., & Chen, C. J. (2023). Aspergillus oryzae Fermentation Extract Alleviates Inflammation in Mycoplasma pneumoniae Pneumonia. Molecules. https://doi.org/10.3390/molecules28031127
Vancouver
Lee HY, Chen CC, Pi CC, Chen CJ. Aspergillus oryzae Fermentation Extract Alleviates Inflammation in Mycoplasma pneumoniae Pneumonia. Molecules. 2023. doi:10.3390/molecules28031127
BibTeX
@article{Lee2023,
author = {Lee, Hui-Yu and Chen, Chun-Chia and Pi, Chia-Chen and Chen, Chun-Jen},
title = {Aspergillus oryzae Fermentation Extract Alleviates Inflammation in Mycoplasma pneumoniae Pneumonia},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28031127}
}
EUVIMED